Abstract
Health-related quality of life is one’s perceived status of life in value systems and cultural settings where they dwell in and in relation to their aspirations, expectations, ideals and fears. Diabetes has always been seen as a disease of affluence but over the years it is increasingly becoming a problem in developing countries. Globally, approximately 1.5 million deaths that occurred in 2012 due to diabetes, 80% of the deaths occurred in the developing nations. There is an increasing problem of non-transmittable diseases in Sub-Saharan Africa region which has brought a change in lifestyles like smoking, physical inactivity and unhealthy diet. Such non-communicable diseases include cardiovascular diseases, neuropathies & renal disorders which are commonly associated as the complications for diabetes mellitus. Measuring the extent an illness has affected health is of significance to the care and management of those individuals with chronic diseases whose remedy is not likely and since they require long-term management and care. Quality of life has a multivariate approach as it highlights information on bodily health, emotional health, functional and social health spheres of an individual’s view of the extent their health has been affected. This measure, therefore, provides holistic care for an individual with diabetes mellitus. This study seeks to solely look at how the wellness of individuals with diabetes mellitus is affected. The research adopted a cross-sectional descriptive design. 165 respondents were selected through systematic random sampling. The researcher used logistic regression whereby patient’s characteristics like foot problem (aOR7.348; p=0.005) and numbness/pain in hands/legs/feet (aOR=0.155; p<0.001) were associated with low quality of life. Over half of the study participants 127 (77%) indicated that their health-related quality of life would be better without diabetes mellitus as depicted by a diabetes specific QoL mean score of-1.88 approximating to “much better” (−2). The overall mean ADDQoL AWI score (−4.48) indicated that the health-related quality of life of the patients was negatively impaired by type two diabetes mellitus. Among the 19 domain specific items, the study participants rated “sex life” as the most negatively impacted/ important (WI= -5.14). In conclusion, type two diabetes mellitus negatively affected the quality of life and diabetes neuropathy which featured as foot problem and numbness of hands/feet needs to be considered as a predisposing factor to low quality of life in diabetics. Care provided should go beyond the standard treatment that looks into how treatment, lifestyle & behavioral modifications affect daily functioning and well-being of patients thus focusing more on the individual patient’s context and ultimately improving the health-related quality of life of type two diabetes mellitus patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance to do the study was sought from the research committee at Moi County Referral hospital through a letter from the Ethics and Research committee of Mount Kenya University. Also, clearance was sought from NACOSTI. The research license number from NACOSTI is NACOSTI/P/22/18413.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
